Plain-English translation of NCT04707105 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a tracking study — not a drug trial — that follows adults hospitalized with a serious type of brain bleeding called primary intracerebral hemorrhage. Researchers at three hospitals in China will collect information about your medical history, hospital care, and recovery to better understand this condition and improve how doctors treat it in the future.
Brain bleeding is a serious condition with high death rates, and doctors don't yet have enough information about what factors predict who will recover well and which treatments work best. This study aims to fill that gap by gathering detailed information from many patients to guide better care.
You likely qualify if…
You likely don't qualify if…
You would be enrolled when you arrive at one of the three participating hospitals in China. Researchers would collect information from your medical records, take blood samples, perform imaging scans like an MRI, and follow up with you over time to track your recovery and outcomes. The study is observational, meaning doctors will monitor your standard medical care rather than assign you to a specific new treatment.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
China
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment target
~856 participants
Started
December 2020
Primary completion
December 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2021.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Feng Gao, MD,PhD
Second Affiliated Hospital, School of Medicine, Zhejiang University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.